23andMe Holding Co. (NASDAQ:ME – Get Free Report) insider Kathy L. Hibbs sold 38,548 shares of 23andMe stock in a transaction that occurred on Thursday, April 18th. The stock was sold at an average price of $0.47, for a total transaction of $18,117.56. Following the transaction, the insider now directly owns 1,252,315 shares in the company, valued at approximately $588,588.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
23andMe Stock Down 4.5 %
23andMe stock opened at $0.48 on Friday. The company’s 50 day moving average price is $0.54 and its two-hundred day moving average price is $0.73. 23andMe Holding Co. has a 52 week low of $0.35 and a 52 week high of $2.21. The stock has a market cap of $233.20 million, a P/E ratio of -0.44 and a beta of 1.27.
23andMe (NASDAQ:ME – Get Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The company reported ($0.17) earnings per share (EPS) for the quarter. 23andMe had a negative return on equity of 52.99% and a negative net margin of 210.48%. The company had revenue of $44.75 million for the quarter, compared to analysts’ expectations of $56.30 million.
Institutional Investors Weigh In On 23andMe
Analyst Upgrades and Downgrades
Separately, Citigroup dropped their target price on shares of 23andMe from $0.85 to $0.47 and set a “neutral” rating on the stock in a research report on Tuesday.
Check Out Our Latest Stock Analysis on ME
23andMe Company Profile
23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.
Featured Stories
- Five stocks we like better than 23andMe
- The How and Why of Investing in Biotech Stocks
- MarketBeat Week in Review – 4/15 – 4/19
- Short Selling: How to Short a Stock
- Comprehensive Analysis of PayPal Stock
- How to Buy Cheap Stocks Step by Step
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for 23andMe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 23andMe and related companies with MarketBeat.com's FREE daily email newsletter.